Copyright
©The Author(s) 2025.
World J Exp Med. Sep 20, 2025; 15(3): 107323
Published online Sep 20, 2025. doi: 10.5493/wjem.v15.i3.107323
Published online Sep 20, 2025. doi: 10.5493/wjem.v15.i3.107323
Table 1 Characteristics of patients included in the study, n (%)
| Patient characteristics | Group 1 (bone marrow aspirate concentrate) | Group 2 (pharmacotherapy) | Group 3 (lifestyle modifications) | P value |
| Age (years) | 42.2 ± 3.3 | 40 ± 4.1 | 39 ± 4.9 | 0.543 |
| Sperm count | 4.75 ± 6.8 | 7.18 ± 5.3 | 11.85 ± 4.7 | 0.064 |
| Sperm motility grade | ||||
| Slow progressive motility | 0 | 1 (10) | 2 (20) | 0.043 |
| Non-progressive motility | 3 (30) | 8 (80) | 5 (50) | |
| Immotile | 4 (40) | 1 (10) | 3 (30) | |
| Azoospermia | 4 (40) | 0 | 0 | |
- Citation: Rangarajan RV, Devadas AG, Padmanapan DJ, Jeyaraman N, Ramasubramanian S, Nallakumarasamy A, Muthu S, Jeyaraman M. Safety and efficacy of autologous bone marrow aspirate concentrate injection for idiopathic male infertility: A comparative study. World J Exp Med 2025; 15(3): 107323
- URL: https://www.wjgnet.com/2220-315X/full/v15/i3/107323.htm
- DOI: https://dx.doi.org/10.5493/wjem.v15.i3.107323